A phase I/II study of REGN5678 (Anti-PSMAxCD28, a costimulatory bispecific antibody) with cemiplimab (anti–PD-1) in patients with metastatic castration-resistant prostate cancer

Zhang, Jingsong ; Stein, Mark N. ; Kelly, William Kevin ; Tsao, Che-Kai ; Falchook, Gerald Steven ; Xu, Yuanfang ; Seebach, Frank A. ; Lowy, Israel ; Mohan, Kosalai Kal ; Kroog, Glenn ; Miller, Elizabeth

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.TPS174-TPS174 [Periódico revisado por pares]

Texto completo disponível